Credit Suisse Ag Revolution Medicines, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 112,301 shares of RVMD stock, worth $4.86 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

112,301

Previous 95,758 17.28%

Holding current value

$4.86 Million

Previous $2.75 Million 31.79%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$26.56 - $33.55 $439,382 - $555,017	16,543 Added 17.28%	112,301 $3.62 Million
Q4 2023 Feb 08, 2024	BUY	$18.35 - $34.12 $406,360 - $755,587	22,145 Added 30.08%	95,758 $2.75 Million
Q3 2023 Nov 13, 2023	SELL	$25.17 - $35.05 $425,196 - $592,099	-16,893 Reduced 18.67%	73,613 $2.04 Million
Q2 2023 Aug 11, 2023	BUY	$20.28 - $27.0 $417,889 - $556,362	20,606 Added 29.48%	90,506 $2.42 Million
Q1 2023 May 10, 2023	BUY	$20.76 - $30.09 $267,720 - $388,040	12,896 Added 22.62%	69,900 $1.51 Million
Q4 2022 Feb 13, 2023	BUY	$17.68 - $25.53 $19,978 - $28,848	1,130 Added 2.02%	57,004 $1.36 Million
Q3 2022 Nov 10, 2022	BUY	$17.46 - $26.0 $268,290 - $399,516	15,366 Added 37.93%	55,874 $1.1 Million
Q2 2022 Aug 12, 2022	SELL	$14.54 - $27.17 $67,930 - $126,938	-4,672 Reduced 10.34%	40,508 $790,000
Q1 2022 May 16, 2022	SELL	$17.31 - $26.4 $19,456 - $29,673	-1,124 Reduced 2.43%	45,180 $1.15 Million
Q4 2021 Feb 14, 2022	BUY	$24.35 - $33.7 $344,576 - $476,888	14,151 Added 44.01%	46,304 $1.17 Million
Q3 2021 Nov 12, 2021	BUY	$23.95 - $33.41 $114,265 - $159,399	4,771 Added 17.42%	32,153 $884,000
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $337,589 - $552,249	11,641 Added 73.95%	27,382 $869,000
Q1 2021 May 14, 2021	SELL	$37.21 - $54.43 $1.36 Million - $1.99 Million	-36,545 Reduced 69.89%	15,741 $723,000
Q4 2020 Feb 12, 2021	BUY	$30.19 - $45.49 $896,582 - $1.35 Million	29,698 Added 131.48%	52,286 $2.07 Million
Q3 2020 Nov 13, 2020	BUY	$22.61 - $34.8 $340,619 - $524,261	15,065 Added 200.25%	22,588 $787,000
Q2 2020 Aug 12, 2020	BUY	$19.65 - $39.34 $147,826 - $295,954	7,523 New	7,523 $237,000

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account